RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Detalles Bibliográficos
Autores principales: Zhou, Shiwei, Obianom, Obinna N., Huang, Jiangsheng, Guo, Dong, Yang, Hong, Li, Qing, Shu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301172/
https://www.ncbi.nlm.nih.gov/pubmed/37376227
http://dx.doi.org/10.3390/pharmaceutics15061623
_version_ 1785064749547913216
author Zhou, Shiwei
Obianom, Obinna N.
Huang, Jiangsheng
Guo, Dong
Yang, Hong
Li, Qing
Shu, Yan
author_facet Zhou, Shiwei
Obianom, Obinna N.
Huang, Jiangsheng
Guo, Dong
Yang, Hong
Li, Qing
Shu, Yan
author_sort Zhou, Shiwei
collection PubMed
description
format Online
Article
Text
id pubmed-10301172
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103011722023-06-29 RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330 Zhou, Shiwei Obianom, Obinna N. Huang, Jiangsheng Guo, Dong Yang, Hong Li, Qing Shu, Yan Pharmaceutics Retraction MDPI 2023-05-30 /pmc/articles/PMC10301172/ /pubmed/37376227 http://dx.doi.org/10.3390/pharmaceutics15061623 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Retraction
Zhou, Shiwei
Obianom, Obinna N.
Huang, Jiangsheng
Guo, Dong
Yang, Hong
Li, Qing
Shu, Yan
RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title_full RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title_fullStr RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title_full_unstemmed RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title_short RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
title_sort retracted: zhou et al. pyrvinium treatment confers hepatic metabolic benefits via β-catenin downregulation and ampk activation. pharmaceutics 2021, 13, 330
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301172/
https://www.ncbi.nlm.nih.gov/pubmed/37376227
http://dx.doi.org/10.3390/pharmaceutics15061623
work_keys_str_mv AT zhoushiwei retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT obianomobinnan retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT huangjiangsheng retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT guodong retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT yanghong retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT liqing retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330
AT shuyan retractedzhouetalpyrviniumtreatmentconfershepaticmetabolicbenefitsviabcatenindownregulationandampkactivationpharmaceutics202113330

Ejemplares similares